This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v5.0.0:
R5
-
STU
).
This
is
the
current
published
version
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Responsible Owner: Pharmacy Work Group | Standards Status : Informative | Compartments : Encounter , Group , Patient , Practitioner |
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationDispense .
Generated Narrative: MedicationDispense meddisp0315
status
:
in-progress
In
Progress
| Reference |
|
|
subject
:
Patient/pat1:
Donald
Duck
"Donald
DUCK"
| Actor |
|
|
authorizingPrescription
:
MedicationRequest/medrx0305
MedicationRequest:
identifier
=
http://www.bmc.nl/portal/prescriptions#12345689 (use: official, );
status
=
completed;
intent
=
order;
authoredOn
=
2015-01-15
type
:
Refill
-
Part
Fill
(
ActCode
#RFP)
quantity
:
30(unit
TAB
from
http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm)
(Details:
http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm
code
TAB
Orderable
Drug
Form
codeTAB
=
'Tablet')
daysSupply
:
10
Day
(Details:
UCUM
code
d
coded
=
'd')
whenPrepared : 2015-06-25T07:13:00+05:00
whenHandedOver : 2015-06-26T07:13:00+05:00
dosageInstruction
sequence : 1
text : 0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day
additionalInstruction : Warning. May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink (qualifier value)
( SNOMED CT #418914006)timing :
Starting 2015-01-15,Once per 6-12hours, Until 2015-01-20hoursasNeededFor : Dysmenorrhea (disorder)
( SNOMED CT #266599000)route : Oral Route
( SNOMED CT #26643006)DoseAndRates
Type Dose[x] Ordered 1 TAB (Details: Orderable Drug Form codeTAB = 'Tablet')
doseAndRateGenerated Narrative: Medication #med0314code : amylase / cellulase / hyoscyamine / lipase / phenyltoloxamine / protease Oral Capsule
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.